IP Library › Granted Patent US 8,410,287
Granted Patent B2
US 8,410,287 · App. 13/193,767 · Granted Apr 2, 2013

Hydrated sodium salt form of celecoxib

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,410,287
App. No.
13/193,767
Granted
Apr 2, 2013
Kind
B2
Abstract

Hydrated celecoxib sodium salt forms and processes to prepare hydrated celecoxib sodium salt forms are disclosed. The celecoxib sodium salt forms are particularly useful and suitable for pharmaceutical applications.

Claims (5)

1. A pentahydrate sodium salt form of celecoxib characterized by the powder x-ray diffraction pattern of FIG. 7 .

2. A method of preparing a pentahydrate sodium salt form of celecoxib, comprising:

dissolving celecoxib in 1.0 N NaOH;

adding 0.3% benzyl alcohol; and

allowing said pentahydrate sodium salt form of celecoxib to crystallize.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jul 2, 2015
From: MCNEIL-PPC, INC.; JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 036049/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2011
From: REMENAR, JULIUS F.; TAWA, MARK D.; PETERSON, MATTHEW L.
To: MCNEIL-PPC, INC.
Reel/Frame 027022/0544 →